Thomas P Soloway Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas P Soloway.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas P Soloway. Thomas P Soloway is a SVP, Operations and CFO in Paratek Pharmaceuticals, Inc. ($PRTK) and an Executive Vice President, CFO in Audentes Therapeutics, Inc. ($BOLD) and a Senior Vice President, CFO in Audentes Therapeutics, Inc. ($BOLD) and a Director in Satsuma Pharmaceuticals, Inc. ($STSA).
Address: C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD., SUITE #110 POINT RICHMOND 94804 CA
Companies in which Thomas P Soloway is an Insider
Audentes Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas P Soloway: Executive Vice President, CFO, Senior Vice President, CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 15 2020
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Paratek Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas P Soloway: SVP, Operations and CFO
Holdings: 20,833 shares
Current Value: $317,703
Latest Transaction: Feb 17 2009
$PRTK Market Capitalization: $346.19M
$PRTK Previous Close: $15.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Satsuma Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas P Soloway: Director
Holdings: 0 shares
Latest Transaction: Jul 07 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Thomas P Soloway
Sentiment: All, BOLD, PRTK, STSA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 07 2020 | STSA | Satsuma Pharmaceut ... | Soloway Thomas P | Director | Option Exercise | A | 27.25 | 20,000 | 545,000 | 20,000 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Soloway Thomas P | Executive Vice Pres ... | Option Exercise | D | 24.74 | 65,000 | 1,608,100 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Soloway Thomas P | Executive Vice Pres ... | Option Exercise | D | 27.39 | 75,000 | 2,054,250 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Soloway Thomas P | Executive Vice Pres ... | Option Exercise | D | 15.26 | 73,781 | 1,125,898 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Soloway Thomas P | Executive Vice Pres ... | Option Exercise | D | 9.50 | 6,263 | 59,491 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Soloway Thomas P | Executive Vice Pres ... | Option Exercise | D | 2.76 | 3,829 | 10,587 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Soloway Thomas P | Executive Vice Pres ... | Sell | U | 60.00 | 183,384 | 11,003,040 | 0 | 183.4 K to 0 (-100.00 %) |